Zobrazeno 1 - 10
of 1 380
pro vyhledávání: '"Walter J. Curran"'
Autor:
Andrew E. Potter, Christopher Baker, Stephen Shumack, Robert Sinclair, Walter J. Curran, David Christie, Bradley Wong, Peter Foley, Peter O’Brien, Lynda Spelman, on behalf of the National Dermatology Radiation Oncology Registry (NDROR) investigators and sites.
Publikováno v:
Journal of Dermatological Treatment, Vol 33, Iss 5, Pp 2634-2642 (2022)
Purpose Evaluate the use of widefield radiation therapy (RT) in the management of extensive skin field cancerization (ESFC) with/without keratinocyte cancer (KC). Methods The National Dermatology Radiation Oncology Registry is a multidisciplinary col
Externí odkaz:
https://doaj.org/article/c0dbad99f7ef41d1aba55d022cfc63d4
Autor:
Tonghe Wang, PhD, Yang Lei, PhD, Joseph Harms, PhD, Beth Ghavidel, MS, Liyong Lin, PhD, Jonathan J. Beitler, MD, Mark McDonald, MD, Walter J. Curran, MD, Tian Liu, PhD, Jun Zhou, PhD, Xiaofeng Yang, PhD
Publikováno v:
International Journal of Particle Therapy, Vol 7, Iss 3, Pp 46-60 (2021)
Purpose: Dual-energy computed tomography (DECT) has been used to derive relative stopping power (RSP) maps by obtaining the energy dependence of photon interactions. The DECT-derived RSP maps could potentially be compromised by image noise levels and
Externí odkaz:
https://doaj.org/article/ef918afd2a69455eaad220367c6604f2
Autor:
Guo Chen, Yin Luo, Kurt Warncke, Youwei Sun, David S. Yu, Haian Fu, Madhusmita Behera, Suresh S. Ramalingam, Paul W. Doetsch, Duc M. Duong, Michael Lammers, Walter J. Curran, Xingming Deng
Publikováno v:
Nature Communications, Vol 10, Iss 1, Pp 1-16 (2019)
Ribonucleotide reductase (RNR) catalyzes the de novo synthesis of deoxyribonucleoside diphosphates to provide dNTP precursors for DNA synthesis. Here the authors show that the availability of dNTPs, DNA replication, and cellular proliferation, are mo
Externí odkaz:
https://doaj.org/article/d07d654e84db43299a467240e28b6a80
Autor:
Mustafa Abugideiri, Eduard Schreibmann, Jeffrey Switchenko, Mark W. McDonald, Jonathan J. Beitler, Walter J. Curran, Deborah Bruner, Pretesh Patel, Wondemagegnhu Tigeneh, Miressa Mijena, Sibo Tian, Anees Dhabaan, Natia Esiashvili, Tian Liu, Arif N. Ali
Publikováno v:
Journal of Global Oncology, Vol 5, Pp 1-16 (2019)
PURPOSE: Transitioning from two-dimensional to three-dimensional treatment planning requires developing contouring skills. Contouring atlases are excellent resources, but they do not provide users active feedback. Developing countries may not have ma
Externí odkaz:
https://doaj.org/article/5e2fdc4fd357411ba8da81a45c2246a4
Autor:
Ke Xu, Dongkyoo Park, Andrew T. Magis, Jun Zhang, Wei Zhou, Gabriel L. Sica, Suresh S. Ramalingam, Walter J. Curran, Xingming Deng
Publikováno v:
Molecular Cancer, Vol 18, Iss 1, Pp 1-16 (2019)
Abstract Background Lung cancer patients with KRAS mutation(s) have a poor prognosis due in part to the development of resistance to currently available therapeutic interventions. Development of a new class of anticancer agents that directly targets
Externí odkaz:
https://doaj.org/article/3f768d5575f04b929f12a8fef492e1de
Publikováno v:
Contemporary Clinical Trials Communications, Vol 12, Iss , Pp 145-153 (2018)
Among various Phase I clinical trial designs, rule-based standard 3 + 3 designs are the most widely utilized for their simplicity and robustness. It is necessary to define crucial operating characteristics of a Phase I clinical trial before it starts
Externí odkaz:
https://doaj.org/article/a76e1efee1cb46848b0e37289e5cad40
Autor:
Joseph M. Unger, Michael LeBlanc, Suzanne George, Norman Wolmark, Walter J. Curran, Peter J. O'Dwyer, Mitchell D. Schnall, Robert S. Mannel, Sumithra J. Mandrekar, Robert J. Gray, Fengmin Zhao, Mariama Bah, Riha Vaidya, Charles D. Blanke
Publikováno v:
Journal of Clinical Oncology. 41:2020-2028
PURPOSE In the United States, the National Cancer Institute National Cancer Clinical Trials Network (NCTN) groups have conducted publicly funded oncology research for 50 years. The combined impact of all adult network group trials has never been syst
Autor:
Maura L. Gillison, Robert L. Ferris, Jonathan Harris, A. Dimitrios Colevas, Loren K. Mell, Christina Kong, Richard C. Jordan, Kevin L. Moore, Minh-Tam Truong, Claudia Kirsch, Arnab Chakravarti, Dukagjin M. Blakaj, David A. Clump, James P. Ohr, John F. Deeken, Michael F. Gensheimer, Nabil F. Saba, Jennifer A. Dorth, David I. Rosenthal, Rom S. Leidner, Randall J. Kimple, Mitchell Machtay, Walter J. Curran, Pedro Torres-Saavedra, Quynh Thu Le
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 115:847-860
Autor:
Roshan S. Prabhu, MD, MS, Brandon E. Turner, MD, Anthony L. Asher, MD, Samuel R. Marcrom, MD, John B. Fiveash, MD, Paul M. Foreman, MD, Robert H. Press, MD, Zachary S. Buchwald, MD, PhD, Walter J. Curran, Jr., MD, Kirtesh R. Patel, MD, William G. Breen, MD, Paul D. Brown, MD, Krishan R. Jethwa, MD, Inga S. Grills, MD, Jessica D. Arden, MD, Lauren M. Foster, BS, Matthew A. Manning, MD, Zachary K. Vaslow, MD, Stuart H. Burri, MD, Scott G. Soltys, MD
Publikováno v:
Advances in Radiation Oncology, Vol 6, Iss 2, Pp 100644- (2021)
Purpose: Postoperative stereotactic radiosurgery (SRS) is associated with up to 30% risk of subsequent leptomeningeal disease (LMD). Radiographic patterns of LMD (classical sugarcoating [cLMD] vs. nodular [nLMD]) in this setting has been shown to be
Externí odkaz:
https://doaj.org/article/b050947fe2d94be3a0ae4260b1afa124
Autor:
Andrew B Lassman, Stephanie L Pugh, Tony J C Wang, Kenneth Aldape, Hui K Gan, Matthias Preusser, Michael A Vogelbaum, Erik P Sulman, Minhee Won, Peixin Zhang, Golnaz Moazami, Marian S Macsai, Mark R Gilbert, Earle E Bain, Vincent Blot, Peter J Ansell, Suvajit Samanta, Madan G Kundu, Terri S Armstrong, Jeffrey S Wefel, Clemens Seidel, Filip Y de Vos, Sigmund Hsu, Andrés F Cardona, Giuseppe Lombardi, Dmitry Bentsion, Richard A Peterson, Craig Gedye, Véronique Bourg, Antje Wick, Walter J Curran, Minesh P Mehta
Publikováno v:
Neuro-Oncology. 25:339-350
Background Approximately 50% of newly diagnosed glioblastomas (GBMs) harbor epidermal growth factor receptor gene amplification (EGFR-amp). Preclinical and early-phase clinical data suggested efficacy of depatuxizumab mafodotin (depatux-m), an antibo